[
  {
    "title": "Revvity Stock Tumbles Despite Expanding Genomics England Alliance",
    "published": 1742575980,
    "posting_price": 106.61000061,
    "close_price": 107.29000092,
    "percent_change": 0.63783914
  },
  {
    "title": "Bretton Fund: \u201cRevvity (RVTY) Has Been On A Roller Coaster Ride The Last Few Years\u201d",
    "published": 1739891913,
    "posting_price": 112.30000305,
    "close_price": 111.73999786,
    "percent_change": -0.4986689
  },
  {
    "title": "Revvity Signals Software\u2019s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners",
    "published": 1713175200,
    "posting_price": 104.08864276,
    "close_price": 102.06372833,
    "percent_change": -1.945375
  },
  {
    "title": "Revvity Inc. stock underperforms Friday when compared to competitors",
    "published": 1712895660,
    "posting_price": 107.19085477,
    "close_price": 103.23079681,
    "percent_change": -3.69439909
  },
  {
    "title": "Revvity (RVTY) Stock Jumps 4.1%: Will It Continue to Soar?",
    "published": 1712757780,
    "posting_price": 107.74945533,
    "close_price": 107.62976074,
    "percent_change": -0.11108603
  },
  {
    "title": "908 Devices: Rare Early-Stage Bioprocess Investment Opportunity",
    "published": 1712753399,
    "posting_price": 107.74945533,
    "close_price": 107.62976074,
    "percent_change": -0.11108603
  },
  {
    "title": "Barclays Keeps Their Hold Rating on Revvity (RVTY)",
    "published": 1712713740,
    "posting_price": 107.74945533,
    "close_price": 107.62976074,
    "percent_change": -0.11108603
  },
  {
    "title": "Revvity (RVTY) Shares Cross Above 200 DMA",
    "published": 1712656740,
    "posting_price": 107.72950682,
    "close_price": 110.44269562,
    "percent_change": 2.51851965
  },
  {
    "title": "Early notable gainers among liquid option names on April 9th",
    "published": 1712652960,
    "posting_price": 107.72950682,
    "close_price": 110.44269562,
    "percent_change": 2.51851965
  },
  {
    "title": "Revvity Now #441 Largest Company, Surpassing J.M. Smucker",
    "published": 1712549340,
    "posting_price": 102.07371042,
    "close_price": 106.14349365,
    "percent_change": 3.98710227
  },
  {
    "title": "Revvity, Inc. (NYSE:RVTY) is largely controlled by institutional shareholders who own 80% of the company",
    "published": 1712413972
  },
  {
    "title": "Revvity To Hold Earnings Call on Monday, April 29, 2024",
    "published": 1712232000,
    "posting_price": 103.04128413,
    "close_price": 101.42533875,
    "percent_change": -1.56825043
  },
  {
    "title": "Bio-Techne: Secular Growth Opportunities Always Exhibit Financial Excellence",
    "published": 1712220187,
    "posting_price": 103.04128413,
    "close_price": 101.42533875,
    "percent_change": -1.56825043
  },
  {
    "title": "Preliminary Injunction Granted to Enforce Revvity s Rights and Cloud Software Group s Obligations Related to Spotfire Software",
    "published": 1712141380,
    "posting_price": 101.74453656,
    "close_price": 102.09365845,
    "percent_change": 0.34313576
  },
  {
    "title": "Revvity Inc. stock outperforms competitors on strong trading day",
    "published": 1712118120,
    "posting_price": 101.74453656,
    "close_price": 102.09365845,
    "percent_change": 0.34313576
  },
  {
    "title": "Preliminary Injunction Granted to Enforce Revvity\u2019s Rights and Cloud Software Group\u2019s Obligations Related to Spotfire Software",
    "published": 1712052000,
    "posting_price": 102.06373512,
    "close_price": 101.95401001,
    "percent_change": -0.10750646
  },
  {
    "title": "Revvity announces preliminary injunction compelling CSG to comply with contract",
    "published": 1712034180,
    "posting_price": 102.06373512,
    "close_price": 101.95401001,
    "percent_change": -0.10750646
  },
  {
    "title": "Three Reasons to Retain Revvity (RVTY) Stock in Your Portfolio",
    "published": 1711991040,
    "posting_price": 104.73702303,
    "close_price": 103.01135254,
    "percent_change": -1.64762224
  }
]